Font Size: a A A
Keyword [percutaneous coronary intervention]
Result: 181 - 200 | Page: 10 of 10
181. Clinic Study Of Tirofiban In Percutaneous Coronary Intervrvention For Acute Myocardial Infarction Patients
182. Relative Factors For Angiographic No Reflow Phenomenon After Primary Percutaneous Coronary Intervention In Patients With Acute Myocardial Infarction
183. Quantitative Analysis Of Ischemic Myocardial Regional Function Before And After Percutaneous Coronary Intervention Therapy By Velocity Vector Imaging
184. Clinical Outcome After Drug-eluting Stent Implantation For The Percutaneous Treatment Of Unprotected Left Main Coronary Artery Disease
185. The Short Clinical Study Of RhBNP (B-Type Natriuretic Peptide) In Patients With Acute Myocardial Infarction (AMI) After Percutaneous Coronary Intervention (PCI)
186. The Analysise Of Result That Using 64-Slice Computed Tomography Angiography In 92 Patients After Percutaneous Coronary Intervention Transplants Stent
187. Analysis Of The Relative Factors For Reperfusion Arrythmia During Percutaneous Coronary Intervention In Patients With Acute Myocardial Infarction
188. Determinates On Prognosis And Quality Of Life Following Percutaneous Coronary Intervention With Stent
189. Quantitative Assessment Of Left Ventricular Function In Patients With Acute Myocardial Infarction After Percutaneous Coronary Intervention By Realtime Threedimensional Echocardiography
190. Influence On Coronary Risk Factor By A Comprehensive Health Education Intervention Programme In Patients After Percutaneous Coronary Intervention
191. Effects Of Pioglitazone Hydrochloride On The Concentrations Of Serum HsCRP And Plasm PAI-1 In The Patients After PCI
192. Long-Term Clinical Outcome Of Patients Undergoing Successful Percutaneous Coronary Intervention For Chronic Total Occlusions In Native Coronary Arteries
193. An Clinical Study Of An Novel Domestic Biodegradable Polymer Sirolimus-eluting Stent For Patients With Coronary Artery Disease
194. Clinical Outcome Of Percutaneous Coronary Intervention Versus Bypass Surgery For Patients With Coronary Artery Disease
195. The Change Of Concentrations Of Plasma Tissue Factor, Tissue Factor Pathway Inhibitor, Interleukin-18 And Interleukin-10 In Patients With Coronary Heart Disease Before And After Percutaneous Coronary Intervention
196. One-year Follow-up Of Clinical Efficacy And Medication Adherence After Percutaneous Coronary Intervention
197. The Implement And Evaluation Of The Clinical Nursing Pathway In The Percutaneous Coronary Intervention
198. Relationships Between Health Value Or Perceived Control Of Health And Health-promoting Lifestyles In Patients Undergoing Percutaneous Coronary Intervention
199. Myocardial Protection Of L-carnitine In Patients With Coronary Heart Disease Undergoing Percutaneous Coronary Intervention
200. The Use Of Plasma B-type Natriuretic Peptide Levels In Evaluation Of Prognosis And Risk Stratification Of Different Therapy In Patients With Acute Coronary Syndrome
  <<First  <Prev  Next>  Last>>  Jump to